2005
DOI: 10.1021/op050039u
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of Kilogram-Scale Sonagashira, Suzuki, and Heck Coupling Routes to Oncology Candidate CP-724,714

Abstract: The synthesis of the anti-cancer compound 2-methoxy-N-(3-{4-[3-methyl-4-(6-methyl-pyridin-3-yloxy)phenylamino]quinazolin-6-yl}-E-allyl)acetamide (CP-724,714) (1) on multikilogram scale using several different synthetic routes is described. Application of the Sonogashira, Suzuki, and Heck couplings to this synthesis was investigated to identify a safe, environmentally friendly, and robust process for the production of this drug candidate. A convergent and selective synthesis of the candidate was identified whic… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
28
0

Year Published

2007
2007
2018
2018

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 72 publications
(28 citation statements)
references
References 17 publications
0
28
0
Order By: Relevance
“…The beneficial effect of ligand‐free conditions led us to examine the reaction of 1a and 2b without using a ligand. However, when Ripin’s protocol16a was employed, no reaction took place after 20 h (Table 3, entry 2). The catalyst system consisting of Pd 2 (dba) 3 [tris(dibenylideneacetone)dipalladium (0)], NaOAc (sodium acetate) and NEt 3 with EtOH as solvent, reported to be highly effective for the regioselective linear arylation of N ‐allyl‐2‐methoxyacetamide by aryl iodide,16b proved to be ineffective in our case (Table 3, entry 3).…”
Section: Resultsmentioning
confidence: 99%
“…The beneficial effect of ligand‐free conditions led us to examine the reaction of 1a and 2b without using a ligand. However, when Ripin’s protocol16a was employed, no reaction took place after 20 h (Table 3, entry 2). The catalyst system consisting of Pd 2 (dba) 3 [tris(dibenylideneacetone)dipalladium (0)], NaOAc (sodium acetate) and NEt 3 with EtOH as solvent, reported to be highly effective for the regioselective linear arylation of N ‐allyl‐2‐methoxyacetamide by aryl iodide,16b proved to be ineffective in our case (Table 3, entry 3).…”
Section: Resultsmentioning
confidence: 99%
“…It has also been reported under Pd‐free, amine‐free, ligand‐free, and solvent‐free conditions as well as with tetrabutylammonium salts as additives and in the presence of water as solvent . Despite reports of alkynylation of quinazolinone/quinazolines with terminal acetylenes, very limited information exists in the literature on the Sonogashira cross‐coupling of 6‐halo‐quinazolinones with terminal alkynes to generate 6‐alkynylated‐substituted quinazolinone derivatives . Hence, development of a catalytic system for the alkynylation at the 6‐position of iodoquinazolinones, bromoquinazolinones, or chloroquinazolinones is synthetically an interesting potential.…”
Section: Introductionmentioning
confidence: 99%
“…From a patient safety perspective, removal of toxic metal residues in the pharmaceutically active ingredient is very important. 10,11 The acceptable level of the platinoids (Pt, Pd, Ir, Rh, Ru) in a compound for oral administra-tion is less than 10 ppm. 12,13 For this reason, the development of new techniques and supports for immobilization of the catalytic metal species has gained increased attention.…”
Section: Introductionmentioning
confidence: 99%
“…12,13 For this reason, the development of new techniques and supports for immobilization of the catalytic metal species has gained increased attention. 10,14 Thus, a heterogeneous palladium catalyst where the metal is immobilized to a solid support allows for easier separation of the catalyst from the reaction mixture at the end of the reaction and enables efficient recycling of the catalyst. With ligand-free catalytic systems, the reaction also becomes more environmentally friendly and the workup is further simplified.…”
Section: Introductionmentioning
confidence: 99%